Business
Drawbacks of the TGA’s cannabis changes for listed pot stocks – Small Caps
Having been subject to a harsh reality check over the last year or so, the ASX-listed cannabis sector is applauding the local medicine regulator’s endorsement of the weed as an effective therapy that should be more freely available to the ailing masses.
Having been subject to a harsh reality check over the last year or so, the ASX-listed cannabis sector is applauding the local medicine regulators endorsement of the weed as an effective therapy that should be more freely available to the ailing masses.
But the path to the pharmacy is likely to be harder than they think, with an emerging supply glut pushing prices to record lows.
In an interim ruling this month, the Therapeutic Goods Administration (TGA) said it intended to downgrade low-dose c…
-
General22 hours agoDonald Trump’s initial 10 per cent tariff takes effect
-
General21 hours agoJaguar Land Rover in UK pauses shipments to US
-
General18 hours agoTexas opens probe into Kellogg’s health claims, dyes
-
General17 hours agoAustralian share market set to dive as threat of US recession grows